NOTICE REGARDING THE AVAILABILITY OF ADMINISTRATIVE SUPPLEMENTS TO SUPPORT - INTERNATIONAL COLLABORATIVE RESEARCH ON DRUG ABUSE RELEASE DATE: December 9, 2003 NOTICE: NOT-DA-04-004 National Institute on Drug Abuse (NIDA) (http://www.nida.nih.gov) RECEIPT DATE: March 1, 2004 PURPOSE The National Institute on Drug Abuse (NIDA) announces the availability of funds to supplement existing NIDA-supported research projects to expand current research efforts, within the scope of the original grant, to conduct research in international sites. Funds will be provided through administrative supplements to take advantage of unique opportunities to support research in all areas of drug-abuse science. Preference will be given to projects that are collaboratively funded by an agency of the host country. Only existing R01 and R21 grants supported by NIDA with at least one year of support remaining at the time of the supplemental award are eligible for supplemental support under this notice. Supplements may be requested for up to 2 years of support, but extend no longer than the parent grant, with funding beginning no later than September 30, 2004. For more information refer to: http://www.drugabuse.gov/Funding/Internationalsupp.html. INQUIRIES Inquiries concerning this notice are strongly encouraged. The opportunity to clarify any issue or questions from potential applicants is welcome. o Direct any questions about this notice to: Steven Gust, Ph.D. Director, NIDA International Program National Institute on Drug Abuse 6001 Executive Boulevard, Room 5274, MSC 9581 Bethesda, MD 20892-9581 Telephone: (301) 443-6480 Email: sgust@nida.nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |